Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares")
-
Shares outstanding
-
125,610,040
-
Total 13F shares
-
63,746,436
-
Share change
-
-3,036,551
-
Total reported value
-
$970,147,653
-
Price per share
-
$15.27
-
Number of holders
-
69
-
Value change
-
-$75,831,576
-
Number of buys
-
30
-
Number of sells
-
30
Institutional Holders of Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) as of Q4 2023
As of 31 Dec 2023,
Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,746,436 shares.
The largest 10 holders included
Two Seas Capital LP, SCOPIA CAPITAL MANAGEMENT LP, VANGUARD GROUP INC, FMR LLC, GOLDMAN SACHS GROUP INC, BARCLAYS PLC, Artemis Investment Management LLP, BANK OF AMERICA CORP /DE/, NORGES BANK, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.